News and Announcements
Revolutionary New Arthritis Treatment from Jardine Pharmaceuticals
- Published April 09, 2015 10:46AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
There is a basic human desire to relieve pain and prolong life, which fuels the search for effective medications. Most drugs come from nature and more than half of the world’s population still rely entirely on plants for their medicines.
Oak is used traditionally for treatment of arthritis. Pharmaceutical efficacy is now achieved through a proprietary extraction process for oak, beating arthritis drugs. The TGA listed oak Polypill™ capsules will be launched through existing distribution networks (Q4 2014).
Jardine Pharmaceuticals has the exclusive worldwide licence for modified polyphenol oak extracts in a complementary medicine format.
Jardine Pharmaceuticals is raising capital to fund further product/market development and research.
Yesterday, Jardine Pharmaceuticals were featured on Current Affair. To watch the video, please click the image below.